Reapplix 3C Patch Retrospective Analysis

Principal Investigator:

Reapplix

Study Abstract:

Reapplix specializes in the biological treatment and healing of chronic wounds. The patented 3CPatch® System is an innovative, evidence-based biological wound therapy made entirely from the patient’s own blood – nothing else. This Circle aggregates retrospective, real-world data focused on the application and outcome of the 3CPatch® System.

Study Type:

Observational

Circle Benefits:

Access and contribute towards a growing repository of real-world data focused on 3CPatch® administration protocols and their outcomes, measured in wound size changes, rate of healing, and patient-reported satisfaction.

Real-World Data Surveys:

Wound Assessment

Circle Type:

Private Circle

Interested in learning more about this Circle?
Additional Resources:

Reapplix 3C Patch Retrospective Analysis

Circle Objective Abstract:

Reapplix specializes in the biological treatment and healing of chronic wounds. The patented 3CPatch® System is an innovative, evidence-based biological wound therapy made entirely from the patient’s own blood – nothing else. This Circle aggregates retrospective, real-world data focused on the application and outcome of the 3CPatch® System.

Real-World Data Surveys:

Wound Assessment

Intervention:

Circle Benefits:

Access and contribute towards a growing repository of real-world data focused on 3CPatch® administration protocols and their outcomes, measured in wound size changes, rate of healing, and patient-reported satisfaction.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES